8 October 2018 - Digital technology could play a major role in creating a system that reimburses medicines based on their efficacy in Spain, according to the country’s pharma trade body.

Farmaindustria, along with the European Federation of Pharmaceutical Industries and Associations and the International Consortium for Health Outcomes Measurement, organised a workshop on Friday to find ways to measure health outcomes and link them to the performance of drugs.

Access to drugs in Spain is a vexed issue, as with many developed countries – the main payer is the cash-strapped taxpayer-funded national health system, although 17 regional committees also have a say in reimbursement decisions and many people cover part of the costs through out-of-pocket contributions.

Read Pharmaphorum article